Fate Therapeutics
FATE
C$1.79
Share price
4.84%
Change (1 day)
-76.18%
Change (1 year)
Categories
Fate Therapeutics (FATE) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : C$0.15 Billion
According to Fate Therapeutics 's latest financial reports the company's total liabilities are C$0.15 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Fate Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | C$0.17 B | -4.24% |
| 2023-12-31 | C$0.18 B | -39.22% |
| 2022-12-31 | C$0.30 B | -2.74% |
| 2021-12-31 | C$0.30 B | 1.88% |
| 2020-12-31 | C$0.30 B | 303.99% |
| 2019-12-31 | C$75.12 M | 4.92% |
| 2018-12-31 | C$71.6 M | 102.65% |
| 2017-12-31 | C$35.33 M | 20.09% |
| 2016-12-31 | C$29.42 M | -29.11% |
| 2015-12-31 | C$41.5 M | 56.57% |
| 2014-12-31 | C$26.5 M | 425.93% |
| 2013-12-31 | C$5.04 M | -92.07% |
| 2012-12-31 | C$63.54 M | 6.72% |
| 2011-12-31 | C$59.54 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | C$3.19 B | 2,006.51% | 🇺🇸 USA |
 Becton Dickinson BDX | C$40.14 B | 26,406.20% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | C$3.90 B | 2,476.75% | 🇺🇸 USA |
 Avidity Biosciences RNA | C$0.17 B | 18.22% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | C$1.58 B | 944.79% | 🇺🇸 USA |